Check out this scientific paper.
Not sure if it’s the same 3e10 patry’s is Using, but it does seem to be quite similar in name and mechanism of action.
http://mct.aacrjournals.org/content/molcanther/early/2012/10/01/1535-7163.MCT-12-0476-T.full.pdf
These scientists also made quite a bold statement about the significance of this type drug in cancer therapy in their abstract,
“The use of cell-penetrating bispecific antibodies in targeted molecular therapy will significantly broaden the spectrum of accessible intracellular targets and may have a profound impact in cancer therapy. Mol Cancer Ther; 11(10); 1– 5. !2012 AACR.“
Ann: PAT-DX1 Crosses Blood Brain Barrier to Reduce Tumour Size, page-86
-
- There are more pages in this discussion • 82 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.001(16.7%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $4.351K | 621.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2130203 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 4749803 | 5 |
View Market Depth
| Last trade - 11.02am 09/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |